22nd Century Group, Inc. (NASDAQ:XXII) Short Interest Up 1,933.3% in December

22nd Century Group, Inc. (NASDAQ:XXII) saw a significant growth in short interest in the month of December. As of December 31st, there was short interest totalling 91,500 shares, a growth of 1,933.3% from the December 15th total of 4,500 shares. Based on an average daily volume of 109,400 shares, the days-to-cover ratio is currently 0.8 days. Approximately 19.5% of the shares of the company are sold short.

Analyst Upgrades and Downgrades

Separately, StockNews.com downgraded 22nd Century Group from a “hold” rating to a “sell” rating in a report on Tuesday, December 31st.

22nd Century Group Trading Up 22.7 %

NASDAQ:XXII opened at $6.00 on Tuesday. 22nd Century Group has a 52 week low of $3.90 and a 52 week high of $581.85. The company has a debt-to-equity ratio of 1.59, a quick ratio of 0.93 and a current ratio of 1.09. The firm’s fifty day moving average is $9.91 and its 200-day moving average is $41.98. The firm has a market cap of $3.32 million, a P/E ratio of -0.27 and a beta of 1.59.

22nd Century Group (NASDAQ:XXII) last issued its quarterly earnings results on Tuesday, November 12th. The biotechnology company reported ($72.90) earnings per share for the quarter. The business had revenue of $5.95 million for the quarter. 22nd Century Group had a negative return on equity of 380.39% and a negative net margin of 144.09%.

Hedge Funds Weigh In On 22nd Century Group

A hedge fund recently bought a new stake in 22nd Century Group stock. Anson Funds Management LP purchased a new position in 22nd Century Group, Inc. (NASDAQ:XXII) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 3,140,452 shares of the biotechnology company’s stock, valued at approximately $691,000. Anson Funds Management LP owned 6.77% of 22nd Century Group at the end of the most recent quarter. Institutional investors own 18.06% of the company’s stock.

About 22nd Century Group

22nd Century Group, Inc, a tobacco products company, engages in the sale and distribution of its own proprietary new reduced nicotine tobacco products. The company offers reduced nicotine content tobacco plants and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands.